Breaking News, Promotions & Moves

ArisGlobal Expands Leadership Team

Introduces a new strategic organizational structure in India and operating model for its offices in Bangalore and Mysore.

Aris, a global drug development technology company, appointed Glenn Renzulli as chief financial officer and Ann-Marie Orange as chief technology officer.   

Renzulli brings over 15 years of executive leadership experience in scaling and supporting software and services businesses. Prior to joining ArisGlobal, Glenn was the CFO of Paya where he helped lead the team through a public listing and an eventual sale to Nuvei Corporation.

Orange brings over 25 years of experience in senior technology roles across several sectors and geographies, including her recent 8-plus year tenure at TransUnion as the CIO for Europe, Ann-Marie will be responsible for technology strategy, architecture, and product development.

“I’m excited to welcome both Glenn and Ann-Marie to ArisGlobal,” said Mike Gordon, CEO ArisGlobal. “Our organization is in a period of unprecedented growth, and I am excited to build on our momentum by adding these two high caliber executives to the ArisGlobal team. Ann-Marie and Glenn are not only elite professionals bringing fresh perspectives in their respective areas of expertise, but they have experience in leading their functions at organizations in similar stages of hyper-growth which will help ensure our readiness to scale.”

In addition, ArisGlobal introduced a new, strategic organizational structure in India and operating model for its offices in Bangalore and Mysore. Effective immediately, the India COEs will be managed by an operating council with members from across all functions. The council will be headed by Hemant Aggarwal, who currently serves as ArisGlobal’s Senior Vice President of Service Delivery.  

“Our teams in India have long been and remain critical to the success of ArisGlobal,” said Russ Schreiber, chief operating officer, ArisGlobal. “In the past, we looked at India as the key location in our company’s origin story. Now, we’ve evolved our global strategic operating model to see Mysore (with a new office campus opening later in 2023) and Bangalore as vital, robust Centers of Excellence supporting our global growth and productivity ambitions.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters